form8k.htm
 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
Form 8-K
 
Current Report
 
 
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
 

 
Date of Report (Date of Earliest Event Reported):
 June 19, 2007
 
 

CAPRIUS, INC.
(Exact name of registrant as specified in its charter)
 
 
DELAWARE
  
0-11914
  
22-2457487
(State or other jurisdiction
of incorporation)
  
(Commission
File Number)
  
(I.R.S. Employer
Identification No.)

 
One University Plaza, Suite 400, Hackensack, New Jersey     
 07601
    (Address of principal executive offices)                
  (Zip Code)

 
Registrant’s telephone number, including area code -
(201) 592-8838
 
 
N/A
 (Former Name or Former Address, if changed since last report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
 
[  ]           Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
[  ]           Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
[  ]           Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
[  ]           Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
Item 1.01             Entry into a Material Definitive Agreement
 
On June  19, 2007, Caprius Inc. (the “Company”) and its wholly-owned subsidiary, Opus Diagnostics, Inc., entered into an Amendment to Royalty Agreement (the “Amendment”) with Seradyn, Inc. (“Seradyn”) with regard to the Royalty Agreement, dated October 9, 2002, among them.  The Amendment provides for a lump sum payment of $500,000 by Seradyn to Opus, plus payment of any royalties due for the period from April 1, 2007 to May 15, 2007, for termination by Opus and the Company of the Royalty Agreement.  The payments are due within ten business days from the entry into the Amendment.
 
Item 9.01.             Financial Statements and Exhibits
 
 (d)         Exhibits
 
 
10.1
Amendment to Royalty Agreement, dated June 19, 2007, by and among the Company, Opus Diagnostics, Inc. and Seradyn, Inc.
 
 
99.1
Press Release, dated June 25, 2007.
 
2
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 

 
CAPRIUS, INC.
   
   
 
By:
/s/Jonathan Joels
   
Jonathan Joels
   
Chief Financial Officer


Dated:  June  25, 2007
 
3
 
Exhibit Index
 
Exhibit
Number                 Exhibit
 
10.1
   
 99.1 Press Release, dated June 25, 2007.
 
4